{"version":"1.0","type":"link","title":"HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.","author_name":"Chen L 외","author_url":"https://prs-insight.online/author/Chen%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/134111","thumbnail_width":1200,"thumbnail_height":630}